S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q3 2023

Deep Track Capital

Periodo: Q3 2023 · Depositato: 2023-11-14
Vedi su SEC EDGAR
AUM
$2.59B
Valore totale del portafoglio
Posizioni
63
Titoli dichiarati
Prima Posizione
INSM
5.8% $151.5M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-11-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
INSMINSMED INC$151.5M5.85%$25.37$111.60+339.9%
5.8%
JAZZJAZZ PHARMACEUTICALS PLC$147.3M5.69%$127.73$243.47+90.6%
5.7%
ITCIINTRA-CELLULAR THERAPIES INC$135.4M5.23%
5.2%
IONSIONIS PHARMACEUTICALS INC$128.6M4.96%$43.43$81.80+88.3%
5.0%
GHGUARDANT HEALTH INC$120.0M4.63%$29.18$167.98+475.7%
4.6%
IMVTIMMUNOVANT INC$107.4M4.15%$34.64$38.79+12.0%
4.2%
ALKSALKERMES PLC$106.4M4.11%$28.07$54.58+94.4%
4.1%
DVAXDYNAVAX TECHNOLOGIES CORP$99.8M3.85%
3.9%
GPCRSTRUCTURE THERAPEUTICS INC$96.5M3.73%$56.60$53.45-5.6%
3.7%
PLRXPLIANT THERAPEUTICS INC$95.4M3.68%$16.05$1.17-92.7%
3.7%
SWTXSPRINGWORKS THERAPEUTICS INC$82.0M3.16%
3.2%
AXSMAXSOME THERAPEUTICS INC$79.7M3.08%$66.85$244.31+265.5%
3.1%
BCYCBICYCLE THERAPEUTICS PLC$70.1M2.71%$19.93$4.35-78.2%
2.7%
TVTXTRAVERE THERAPEUTICS INC$65.9M2.54%$8.42$56.92+576.0%
2.5%
NTLAINTELLIA THERAPEUTICS INC$63.2M2.44%$29.41$17.56-40.3%
2.4%
EDITEDITAS MEDICINE INC$55.4M2.14%$7.14$3.65-48.9%
2.1%
GERNGERON CORP$54.5M2.10%$1.99$1.36-31.7%
2.1%
VRNAVERONA PHARMA PLC$52.0M2.01%
2.0%
APGEAPOGEE THERAPEUTICS INC$51.4M1.98%$20.40$132.91+551.5%
2.0%
PACBPACIFIC BIOSCIENCES CALIF IN$50.1M1.93%$8.05$1.68-79.1%
1.9%
VRDNVIRIDIAN THERAPEUTICS INC$45.5M1.75%$14.60$19.40+32.9%
1.8%
NVCRNOVOCURE LTD$40.4M1.56%$15.59$17.20+10.3%
1.6%
HLVXHILLEVAX INC$39.0M1.51%
1.5%
RPTXREPARE THERAPEUTICS INC$37.1M1.43%
1.4%
AGENAGENUS INC$35.8M1.38%$21.00$3.49-83.4%
1.4%
FDMT4D MOLECULAR THERAPEUTICS IN$35.4M1.37%$11.81$13.00+10.1%
1.4%
AUTLAUTOLUS THERAPEUTICS PLC$35.0M1.35%$2.18$1.58-27.5%
1.4%
NBIXNEUROCRINE BIOSCIENCES INC$33.8M1.30%$111.79$174.26+55.9%
1.3%
TERNTERNS PHARMACEUTICALS INC$30.2M1.16%$4.91
1.2%
RAPTRAPT THERAPEUTICS INC$24.9M0.96%
1.0%

Attività Trimestre su Trimestre

Q3 2023 vs. Q2 2023

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
APGEAPOGEE THERAPEUTICS INC$51.4M+551.5%
NVCRNOVOCURE LTD$40.4M+10.3%
HLVXHILLEVAX INC$39.0M
NBIXNEUROCRINE BIOSCIENCES INC$33.8M+55.9%
ANABANAPTYSBIO INC$24.2M
OLMAOLEMA PHARMACEUTICALS INC$23.9M
AMLXAMYLYX PHARMACEUTICALS INC$23.1M
BNTXBIONTECH SE$21.7M

Posizioni Chiuse (8)

TickerEmittenteNozionale
ORTXORCHARD THERAPEUTICS PLC$10.6M
INZYINOZYME PHARMA INC$9.2M
ZNTLZENTALIS PHARMACEUTICALS INC$8.5M
MLTXMOONLAKE IMMUNOTHERAPEUTICS$5.5M
FGENFIBROGEN INC$2.1M
ALLKALLAKOS INC$1.0M
IMUXIMMUNIC INC$0.8M
INKTXXXXMINK THERAPEUTICS INC$0.7M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
TERNTERNS PHARMACEUTICALS INC$20.6M+445.9%
PACBPACIFIC BIOSCIENCES CALIF IN$30.8M+313.5%-79.1%
AXSMAXSOME THERAPEUTICS INC$52.1M+196.9%+265.5%
GHGUARDANT HEALTH INC$66.3M+170.0%+475.7%
NTLAINTELLIA THERAPEUTICS INC$29.2M+139.4%-40.3%
VRDNVIRIDIAN THERAPEUTICS INC$15.0M+131.6%+32.9%
MORFMORPHIC HLDG INC$-1.6M+117.1%
EDITEDITAS MEDICINE INC$27.0M+105.6%-48.9%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ETNB89BIO INC$-8.1M-81.9%
CMPSCOMPASS PATHWAYS PLC$-3.2M-51.6%
IMVTIMMUNOVANT INC$4.6M-48.4%+12.0%
IPSCCENTURY THERAPEUTICS INC$-2.1M-46.9%
ATXSASTRIA THERAPEUTICS INC$-6.4M-38.9%
ABOSACUMEN PHARMACEUTICALS INC$-8.4M-35.8%
GPCRSTRUCTURE THERAPEUTICS INC$-13.5M-27.6%-5.6%
BEAMBEAM THERAPEUTICS INC$-17.6M-22.9%
Torna agli Hedge Fund
Deep Track Capital Q3 2023 13F Filing — Holdings & Portfolio | MarketsFN